Multidisciplinary management of advanced lung neuroendocrine tumors.


The optimal clinical management of aggressive/advanced lung neuroendocrine tumors (NETs) is still debated, due to their rarity and the lack of prospective randomized studies. Results derive from retrospective mono-Institutional series, and few dedicated prospective trials, recently designed, are still ongoing. In low-grade tumors [bronchial carcinoids (BCs… (More)
DOI: 10.3978/j.issn.2072-1439.2015.04.20


  • Presentations referencing similar topics